Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Consulting agrmnt
Director departure
Appointed director
BioSig Technologies, Inc. (BSGM) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 D Form D - Notice of Exempt Offering of Securities:
09/27/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Form of Warrant",
"Form of Laidlaw Warrant",
"Form of Securities Purchase Agreement"
09/27/2023 D Form D - Notice of Exempt Offering of Securities:
08/24/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals BioSig Technologies, Inc. , a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today is providing an update since the launch of BioSig’s established technology team with external partners and collaborators to advance the research and development of an artificial intelligence medical device platform. On July 20, 2023, we announced the inclusion of BioSig AI Sciences, Inc., a majority owned subsidiary of the Company , in Nvidia’s Inception partnership program, providing our team access to engineering and technology support. On July 23, 2023, BAIS completed its seed round of funding of $2.2 million. The fundin..."
08/23/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "BioSig Introduces New Subscription Model for PURE EP™ Platform, Offering Quicker Access to Latest Features, Customizations"
08/22/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "BioSig's PURE EP™ Platform Debuts New Automated Features in First Patient Cases Latest Software Release Supports Electrophysiologists with Visualizing Heart Patterns Difficult to Recognize with the Naked Eye Westport, CT, Aug. 22, 2023 -- BioSig Technologies, Inc. , a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, announced today the release of new software features for the PURE EP™ Platform. The novel software features were successfully leveraged for the first time during patient cases conducted at the Kansas City Heart Rhythm Institute . Building on the FDA-cleared platform's proprietary combination of advanced hardware and software, PURE EP™'s latest software debuts two new features designed to harness t..."
08/18/2023 8-K Quarterly results
08/18/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/01/2023 D Form D - Notice of Exempt Offering of Securities:
07/31/2023 8-K Quarterly results
07/21/2023 8-K Quarterly results
07/20/2023 8-K Quarterly results
06/30/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Form of Securities Purchase Agreement"
05/26/2023 D Form D - Notice of Exempt Offering of Securities:
05/19/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "New Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating Arrhythmias"
04/28/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Corporate Presentation dated April 2023 (furnished herewith pursuant to Item 7.01)",
"Corporate Summary dated April 2023 (furnished herewith pursuant to Item 7.01)"
04/28/2023 D Form D - Notice of Exempt Offering of Securities:
04/21/2023 8-K Quarterly results
04/05/2023 D Form D - Notice of Exempt Offering of Securities:
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/29/2023 8-K Quarterly results
03/20/2023 D Form D - Notice of Exempt Offering of Securities:
02/22/2023 8-K Quarterly results
02/14/2023 D Form D - Notice of Exempt Offering of Securities:
02/13/2023 8-K Quarterly results
02/13/2023 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
02/09/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "BioSig Technologies, Inc. 2023 Long-Term Incentive Plan"
02/08/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Form of Warrant",
"Form of January Laidlaw Warrant",
"Form of February Laidlaw Warrant",
"Form of Securities Purchase Agreement"
02/07/2023 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "General Release and Severance Agreement by and between BioSig Technologies, Inc. and Steve Chaussy"
02/07/2023 8-K Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce...
Docs: "Form of Laidlaw Warrant",
"General Release and Severance Agreement by and between BioSig Technologies, Inc. and Steve Chaussy",
"Vice President, Investor Relations 55 Greens Farms Road, 1st Floor"
01/31/2023 D Form D - Notice of Exempt Offering of Securities:
01/31/2023 D Form D - Notice of Exempt Offering of Securities:
01/26/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Form of Warrant",
"Form of Securities Purchase Agreement"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy